Company / Shareholders' Equity
CVS Health Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$75.2B
FY2025
5-year range
$71.5B / $76.5B
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#2 of 160
Health Care
What the data says
Among 160 Health Care companies, CVS Health is in the top 1% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from $36.8B in FY2016 to $76.5B in FY2023.
Based on SEC 10-K filings.
$75.2B in FY2025 with a 5-year CAGR of +1.6%. Ranks 2nd among 160 companies in Health Care.
Remained stable around $75.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 160This company $75.2B Sector average $5.0B
▼
+1391.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 0.5% year-over-year.
- Ranks #2 out of 160 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.2B | -0.5% |
| FY2024 | $75.6B | -1.2% |
| FY2023 | $76.5B | +7.0% |
| FY2022 | $71.5B | -4.8% |
| FY2021 | $75.1B | +8.2% |
| FY2020 | $69.4B | +8.7% |
| FY2019 | $63.9B | +9.7% |
| FY2018 | $58.2B | +54.5% |
| FY2017 | $37.7B | +2.3% |
| FY2016 | $36.8B | -1.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026